NCT03187496 - Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 11, 2017

Primary Completion Date

June 1, 2017

Study Completion Date

June 14, 2017

Conditions

NASH

Interventions

DRUG

Midazolam

Each subject will receive midazolam on Days 1 and 12.

DRUG

Caffeine

Each subject will receive caffeine on Days 1 and 12.

DRUG

Rosuvastatin

Each subject will receive rosuvastatin on Days 2 and 13.

DRUG

EDP-305

Each subject will receive EDP-305 on Days 5 through 15.

Trial Locations (1)

Pharmaceutical Research Associates, Inc.,, Lenexa